United Therapeutics UTHR Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's accounts receivable?
- United Therapeutics (UTHR) reported accounts receivable of $312M in Q1 2026.
- How has United Therapeutics's accounts receivable changed year-over-year?
- United Therapeutics's accounts receivable decreased by 3.1% year-over-year, from $322M to $312M.
- What is the long-term trend for United Therapeutics's accounts receivable?
- Over 5 years (2020 to 2025), United Therapeutics's accounts receivable has grown at a 17.3% compound annual growth rate (CAGR), from $157.4M to $350.2M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.